UMIN000052180
Effects of consumption of the beverage containing fulvic acid and silicon on fatigue and sleep quality in healthy Japanese subjects who have received mRNA vaccination for COVID-19 at least three times
Effects of consumption of the beverage containing fulvic acid and silicon on fatigue and sleep quality in healthy Japanese subjects who have received mRNA vaccination for COVID-19 at least three times: a randomized, placebo-controlled, parallel-group comparison study
ORTHOMEDICO Inc.·Not Applicable·University Hospital Medical Information Network·dietary supplementRecruiting
Study focus
- Disease/Condition
- Healthy Japanese subjects
- Study type
- Interventional
- Intervention type
- dietary supplement
Sponsor & location
- Primary sponsor
- ORTHOMEDICO Inc.
- Location
- Japan
Timeline & enrollment
- Phase
- Not Applicable
- Start date
- Sep 12, 2023
- End date
- N/A
ICD-10 classifications
Japanese encephalitis
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000052180
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000052180 through Pure Global AI's free database. This Not Applicable trial is sponsored by ORTHOMEDICO Inc. and is currently Recruiting. The study focuses on Healthy Japanese subjects.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.